See more : Pearl Holdings Acquisition Corp (PRLHW) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Eni S.p.A. (ENI.DE) Income Statement Analysis – Financial Results
- SandRidge Energy Inc (SDRDW) Income Statement Analysis – Financial Results
- Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) Income Statement Analysis – Financial Results
- Tigrent Inc. (TIGE) Income Statement Analysis – Financial Results
- Jiya Eco-Products Limited (JIYAECO.NS) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHWF)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 511.58M | 460.08M | 179.50M | 77.46M | 0.00 |
Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M | 0.00 |
Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M | 0.00 |
Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M | 0.00 |
Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
SG&A | 617.45M | 195.73M | 124.42M | 111.24M | 0.00 |
Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M | 0.00 |
Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M | 0.00 |
Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M | 161.14K |
EBITDA | -416.24M | 13.64M | -32.08M | -55.56M | 0.00 |
EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% | 0.00% |
Operating Income | -416.24M | -39.37M | -74.10M | -81.82M | 0.00 |
Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% | 0.00% |
Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M | 0.00 |
Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M | 0.00 |
Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% | 0.00% |
Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M | 0.00 |
Net Income | -421.48M | -146.85M | -133.20M | -106.73M | 0.00 |
Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% | 0.00% |
EPS | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
EPS Diluted | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
Weighted Avg Shares Out | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Weighted Avg Shares Out (Dil) | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Top Marijuana Stocks To Buy Today In The Stock Market?
Columbia Care Inc. (CCHWF) Q3 2022 Earnings Call Transcript
Top Cannabis Stocks To Watch Under $2 Now
The 3 Likeliest States to Legalize Marijuana on Election Day
Sean 'Diddy' Combs makes his entrance into the cannabis space with $185M deal for divested Cresco and Columbia Care assets
Evaluating Columbia Care Ahead Of Its Pending Merger With Cresco Labs
3 Cannabis Stock Predictions for 2023
These Marijuana Stocks Are Building More Momentum
Best US Cannabis Stocks To Watch Mid October
Best Marijuana Stocks To Buy? US Cannabis Stocks On Watch Now
Source: https://incomestatements.info
Category: Stock Reports